Congestive Heart Failure - The Left Main and Coronary Artery Bifurcation Lesion Summit (CBS)

Ejection Fraction Pros and Cons: JACC State-of-the-Art Review
Improving the Use of Primary Prevention Implantable Cardioverter-Defibrillators Therapy With Validated Patient-Centric Risk Estimates
Wireless pulmonary artery pressure monitoring guides management to reduce decompensation in heart failure with preserved ejection fraction
Phenotypic Refinement of Heart Failure in a National Biobank Facilitates Genetic Discovery
Proteomics to Improve Phenotyping in Obese Patients with Heart Failure with Preserved Ejection Fraction
Cardiac resynchronization therapy with a defibrillator (CRTd) in failing heart patients with type 2 diabetes mellitus and treated by glucagon-like peptide 1 receptor agonists (GLP-1 RA) therapy vs. conventional hypoglycemic drugs: arrhythmic burden, hospitalizations for heart failure, and CRTd responders rate
21st Century CE: The New Iron Age?
Criteria for Iron Deficiency in Patients With Heart Failure
Effect of SGLT2-Inhibitors on Epicardial Adipose Tissue: A Meta-Analysis
2018 ACC/AHA/HRS Guideline on the Evaluation and Management of Patients With Bradycardia and Cardiac Conduction Delay: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society

Original Research

2018 Apr;198:145-151.

JOURNAL：Am J Cardiol.

Rationale and design of the comParIson Of sacubitril/valsartaN versus Enalapril on Effect on nt-pRo-bnp in patients stabilized from an acute Heart Failure episode (PIONEER-HF) trial

Velazquez EJ, Morrow DA, DeVore AD et al.

5945

Keywords: sacubitril; valsartan; enalapril; NT-proBNP; acute Heart Failure episode

FULL TEXT PDF